Casanillo, Matias V.

HRN: 27-93-19  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/09/2025
10/16/2025
IV
4.5g
Q8
DM Foot Ulcer
Waiting Final Action 
10/09/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/09/2025
10/16/2025
IV
600
Q6
Dm Foot Ulcer
Waiting Final Action 
10/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/16/2025
10/30/2025
IV
2.25mg
Q6
DM Foot
Waiting Final Action 
10/31/2025
LEVOFLOXACIN 500MG (TAB)
10/31/2025
11/06/2025
PO
500mg
Od
CAP-HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: